Integra Brass Face Investor Suit Over FDA Compliance Lapses
By Sydney Price · May 14, 2025, 9:13 PM EDT
Executives and directors of medical device company Integra Lifesciences Inc. were hit with a derivative suit alleging they misled investors about the company's compliance with regulatory standards for over five years,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login